Gulick, Roy M.

Top Publications

Top Publications Authored or Co-Authored by "Gulick, Roy M."

• Cabotegravir for HIV prevention in cisgender men and transgender women

  New England Journal of Medicine, Volume 385, No. 7, Year 2021, Citations 268
• Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial

  The Lancet, Volume 383, No. 9927, Year 2014, Citations 133
• Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings

  PLoS Medicine, Volume 9, No. 8, Article e1001290, Year 2012, Citations 126
• Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study

  The Lancet Infectious Diseases, Volume 15, No. 7, Year 2015, Citations 96
• ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants with HIV-1 RNA <500000 Copies/mL

  Clinical Infectious Diseases, Volume 66, No. 11, Year 2018, Citations 78